Self-Management and Resilience Trajectories in African American Adults With Hypertension
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05308914 |
Recruitment Status :
Recruiting
First Posted : April 4, 2022
Last Update Posted : October 5, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Hypertension (HTN) rates have increased worldwide, but the most significant increase in the incidence of morbidity and mortality has been in African Americans (AA)1,2 (43% vs 27% for other U.S. population groups). Despite evidence of positive benefits from lifestyle modification (healthy diet, reduced sodium intake, increased physical activity, smoking cessation) and prescribed antihypertensive therapy (AHT) many AA with HTN do not adhere to their treatment regimens. Consistent, effective lifelong self-management is required to sustain optimal BP control and thus reduce morbidity and mortality. Self-managing HTN to a blood pressure (BP) <130/80 mm Hg presents challenges such as juggling multiple medications and health care providers, dealing with complex recommendations and treatment regimens, and coping with negative emotional states. Few studies have examined the biopsychosocial mechanisms that foster effective HTN self-management and resilience among AA living with HTN. Understanding the mechanisms that influence HTN self-management and resilience in AA holds the promise of new modifiable targets for behavior-change interventions.
This study explores the relationship among resilience precursors on hypertension (HTN) self-management behaviors, stress response, and the effects that these relationships have on health outcomes-health-related quality of life (HRQOL) and blood pressure (BP) in African Americans (AA) with HTN over a 6-month period.
Condition or disease |
---|
Hypertension Self-Management Quality of Life Compliance, Medication Compliance, Treatment Compliance, Patient |
This study identifies profiles of self-management and the resilience trajectories in AA with HTN can lead to culturally appropriate, patient-centered interventions that improve their HTN self-management, quality of life, and long-term compliance.
This study aims to:
- Assess the association among resilience precursors (dispositional optimism and resilience, emotion regulation); stress response (physiological: cortisol, interleukins [IL-6] and psychological: depression cognitions, perceived stress); hypertension self management behaviors (self-efficacy for chronic disease management, medication adherence to antihypertensives); and health outcomes (HQROL and BP) in AA with HTN at baseline and months 3 and 6.
- Determine if stress response mediates the relationship between resilience precursors and health outcomes over time when controlling for risk regulators.
- Determine if self-management behaviors mediates the relationship between resilience precursors and health outcomes over time when controlling for risk regulators.
- Identify resilience trajectory patterns and factors that influence HTN self-management behaviors over time.
Study Type : | Observational |
Estimated Enrollment : | 125 participants |
Observational Model: | Other |
Time Perspective: | Other |
Official Title: | Self-Management and Resilience Trajectories in African American Adults With Hypertension |
Actual Study Start Date : | March 1, 2022 |
Estimated Primary Completion Date : | August 31, 2023 |
Estimated Study Completion Date : | November 30, 2023 |

Group/Cohort |
---|
Resilience Study Cohort
Observational, descriptive longitudinal cohort design. See inclusion and exclusion criteria for more information
|
- systolic and diastolic Blood Pressure [ Time Frame: Baseline - 6 months ]Measure of participants' in clinic blood pressure (average of three blood pressure readings).
- PROMIS Global Health-10 [health-related quality of life] [ Time Frame: Baseline - 6 months ]Total summed score on PROMIS Global Health-10 that range from 4-20.Higher scores indicate greater health-related quality of life.
Biospecimen Retention: None Retained
Specimens: Blood will be obtained at baseline, 3 months, and 6 months. Subjects will have blood samples (2 tubes, 1 teaspoon=5 ml each tube) drawn for Interleukin 6 (IIL-6) and High sensitivity C-reactive Protein (CRP) and cortisol serum to assess (~10 minutes to complete).
Hair samples will be obtain at baseline and 6 months for Cortisol Concentration

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 25 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- Self-identify as African American
- 25 years of age or older
- Diagnosed with hypertension and prescribed one antihypertensive medication
- BP >130/80 mmHg
- Have at least one additional chronic health conditions
- Able to read/understand English
Exclusion Criteria:
- Unable to give informed consent or judged to have impaired cognitive ability or severe memory
- Have experienced a major CVD event or procedure (e.g., myocardial infarction, stroke, heart surgery) within the past year

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05308914
Contact: Carolyn H Still, PhD | 216-368-6338 | carolyn.still@case.edu |
United States, Ohio | |
University Hospitals Cleveland Medical Center | Recruiting |
Cleveland, Ohio, United States, 44106 | |
Contact: Carolyn H Still, PhD 216-844-3798 carolyn.still@uhhospitals.org |
Principal Investigator: | Carolyn Still, PhD | Case Western Reserve University, School of Nursing |
Responsible Party: | Carolyn Still, Assistant Professor, Case Western Reserve University |
ClinicalTrials.gov Identifier: | NCT05308914 |
Other Study ID Numbers: |
1R21NR020489-01A1 ( U.S. NIH Grant/Contract ) |
First Posted: | April 4, 2022 Key Record Dates |
Last Update Posted: | October 5, 2022 |
Last Verified: | October 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Hypertension Self-Management Resilience |
Hypertension Vascular Diseases Cardiovascular Diseases |